登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603352 证券简称：至信股份 公告编号：2026-007 重庆至信实业股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东会召开日期：2026年3月4日 (一)股东会类型和届次 2026年第一次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2026年3月4日 14点 00分 召开地点：重庆市两江新区鱼嘴镇长惠路29号公司会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2026年3月4日 至2026年3月4日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东会召开当日的交易时间 段，即9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票平台的投票时间为 ...

证券代码：600237 证券简称：铜峰电子 公告编号：2026-007 安徽铜峰电子股份有限公司 关于控股股东增持股份计划实施完毕暨增持计划实施结果的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 已披露增持计划情况 安徽铜峰电子股份有限公司（以下简称"公司"或"铜峰电子"）于2025年2月7日发布《关于控股股东以专 项贷款和自有资金增持公司股份计划的公告》（临2025-007），公司控股股东铜陵中旭产业投资有限公 司（以下简称"中旭产投"）基于对公司未来发展前景的信心及中长期投资价值的认可，拟自该公告披露 之日起12个月内通过上海证券交易所交易系统以集中竞价交易方式增持公司A股股份，增持总金额不低 于人民币1.5亿元，不超过人民币3亿元（以下简称"本次增持计划")。 ● 增持计划的实施结果 2025年3月4日至2026年1月13日期间，公司控股股东中旭产投通过上海证券交易所交易系统以集中竞价 交易方式累计增持公司股票22,765,876股，增持比例为3.61%，累计增持金额15,125.9 ...

Core Viewpoint - The company, Shanghai Rongtai Health Technology Co., Ltd., has announced its expected daily related transactions for the year 2026, which will not require shareholder approval and are deemed to not affect the company's independence or harm shareholder interests [2][3][4]. Group 1: Daily Related Transactions Overview - The board of directors approved the expected daily related transactions for 2026 on February 6, 2026, with a unanimous vote of 6 in favor and no abstentions or oppositions [3][4]. - Independent directors reviewed and approved the proposal, confirming that the expected transactions are necessary for daily operations and comply with market pricing principles [3][4]. - The audit committee also endorsed the proposal, stating that the transactions align with the interests of the company and its shareholders, ensuring no impact on the company's independence [4]. Group 2: Expected Transaction Amounts and Categories - The total expected amount for daily related transactions in 2026 is 69.70 million yuan (approximately 6,970.27 thousand yuan) [6]. - The transactions are based on market prices and are structured to ensure fairness and transparency, with contracts already signed with related parties for the year [8]. Group 3: Related Parties and Transaction Purpose - The related parties involved include Jiaxing Ouyuan Motor Co., Ltd. and Suzhou Shangse Metal Products Co., Ltd., both of which are operational and have strong performance records [8]. - The transactions are essential for the company's normal business operations and are expected to facilitate the execution of daily business activities without compromising the interests of shareholders [8].

Core Viewpoint - The announcement details the completion of the repurchase and cancellation of restricted stocks by Harbin Sanlian Pharmaceutical Co., Ltd., involving a total of 3,000 shares, which represents 0.0009% of the company's total share capital before the repurchase [2][11]. Group 1: Repurchase and Cancellation Details - The repurchase price for the restricted stocks was set at 6.48 yuan per share, totaling 19,440 yuan for the repurchase [2][10]. - Following the cancellation, the company's total share capital decreased from 316,357,550 shares to 316,354,550 shares [2][11]. - The repurchase was completed on February 6, 2026, as confirmed by the China Securities Depository and Clearing Corporation [2][10]. Group 2: Background of the Stock Incentive Plan - The 2022 stock incentive plan was approved by the board on July 29, 2022, and involved granting 6,775,183 shares to 175 eligible participants at a price of 6.98 yuan per share [3][5]. - The plan included provisions for repurchasing shares from participants who no longer met the eligibility criteria due to voluntary resignation [9][10]. - The company adjusted the repurchase price from 6.68 yuan to 6.48 yuan per share prior to the cancellation [10]. Group 3: Impact and Future Arrangements - The cancellation of 3,000 shares will not significantly impact the company's financial metrics or daily operations [12]. - The company will proceed with the necessary legal and regulatory procedures for the share cancellation and registration [12].

Group 1 - The company plans to provide a guarantee of up to RMB 35 million for its wholly-owned subsidiary, Mingzhi International Trade (Shanghai) Co., Ltd., to ensure the performance of contracts with Panasonic Electric Works (China) Co., Ltd. for electronic components from April 1, 2026, to March 31, 2027 [1][5][36] - The guarantee will cover all payment obligations, including principal, default liabilities, and compensation responsibilities, with a term lasting six months after the last payment obligation is fulfilled [1][5][36] - The board of directors unanimously approved the guarantee proposal on February 6, 2026, and it does not require shareholder approval [2][7] Group 2 - The company has a total of RMB 31.5 million in external guarantees, which accounts for approximately 10.78% of the latest audited net assets, all of which are guarantees for its controlling subsidiaries [8][29] - There are no overdue guarantees or guarantees involving litigation as of the announcement date [8][29] Group 3 - The company is also set to provide a joint liability guarantee for its wholly-owned subsidiary, Mingzhi Industries Development (Shanghai) Co., Ltd., for a comprehensive credit application to banks, with a total guarantee amount not exceeding RMB 80 million [22][24][40] - This guarantee is intended to support the subsidiary's operational funding needs and is expected to last up to 15 years [24][27] - The board of directors has approved this guarantee proposal, which will also be submitted for shareholder approval [25][28]

Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for Longxun Semiconductor (Hefei) Co., Ltd., with a total of 58,934,368 shares set to be released on February 24, 2026, following a 36-month lock-up period since the company's initial public offering [2][4][5]. Group 1: Listing Details - The total number of shares to be listed is 58,934,368, which represents 44.20% of the company's total share capital [19]. - The shares will be available for trading starting on February 24, 2026, due to the non-trading day on February 21, 2026 [4][19]. - The shares being released are part of the initial public offering and have been under a lock-up period of 36 months [5][19]. Group 2: Share Capital Changes - The company initially issued 17,314,716 shares during its IPO, resulting in a total share capital of 69,258,862 shares [5][6]. - Following the issuance of restricted stock and other equity distributions, the total share capital has increased to 132,704,525 shares as of April 2025 [8][9]. - The company has undergone several changes in share capital due to stock incentives and equity distributions since its IPO [6][7][8][9]. Group 3: Shareholder Commitments - The actual controller, Feng Chen, and related parties have committed to a 36-month lock-up period for their shares, during which they will not transfer or manage their shares [10][11]. - If the stock price falls below the IPO price within six months post-listing, the lock-up period will automatically extend by an additional six months [10][11]. - The commitments made by shareholders are irrevocable and will remain in effect regardless of any changes in their positions within the company [14][16]. Group 4: Regulatory Compliance - The underwriting institution, China International Capital Corporation, has confirmed that the shareholders have adhered to their commitments regarding the restricted shares [18]. - The listing and circulation of the restricted shares comply with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [18].

润建股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002929 证券简称：润建股份 公告编号：2026-005 根据《深圳证券交易所股票上市规则》及《公司章程》等相关规定，本次清算及注销事项不构成关联交 易，亦不构成重大资产重组，无需提交公司董事会及股东会审议。 关于全资子公司与专业投资机构合作投资的 进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大 遗漏。 一、合作投资基本情况 润建股份有限公司（以下简称"公司"）全资子公司润建智慧能源有限责任公司（以下简称"润建能源"） 作为有限合伙人与普通合伙人天津华景节能环保科技有限公司、普通合伙人河北景科能控新能源科技有 限公司及有限合伙人河北辰平新能源开发有限公司签署了《华景（天津）碳中和股权投资基金合伙企业 （有限合伙）合伙协议》，共同投资华景（天津）碳中和股权投资基金合伙企业（有限合伙）（以下简 称"华景碳中和基金"）。 华景碳中和基金募集规模为人民币50,200万元，润建能源作为有限合伙人以自有资金认缴出资人民币 10,000万元，出资比例为19.92%，其中，首期募集金额为人民 ...

Core Viewpoint - The stock of Beijing Hanjian Heshan Pipeline Co., Ltd. has experienced significant price fluctuations, raising concerns about irrational speculation and trading risks in the secondary market [2]. Group 1: Stock Trading Risks - The company's stock price increased by a cumulative deviation of 20% over two consecutive trading days on February 4 and 5, 2026, indicating abnormal trading activity [2]. - On February 6, 2026, the stock hit the daily limit again, reflecting substantial short-term price volatility and potential irrational speculation risks [2]. - The company's latest price-to-book ratio is 11.75 times, significantly higher than the industry average of 2.00 times, suggesting overvaluation compared to peers [2]. Group 2: Operational Risks - The company is currently operating normally, with no significant changes in the internal or external business environment, and its main business remains the production of prestressed concrete pipes (PCCP) [3]. - The company faces intense competition in the market, with risks associated with not winning bids for sales contracts, which are primarily obtained through bidding processes [3]. - The company anticipates a net loss for the year 2025, with projected losses ranging from 8 million to 12 million yuan [3]. Group 3: Shareholder Risks - The controlling shareholder, Beijing Hanjian Group Co., Ltd., holds 34.17% of the company's total shares, with 85.92% of these shares pledged and 9.84% frozen due to judicial actions [4]. - The high percentage of pledged and frozen shares poses risks related to the controlling shareholder's financial stability and potential impacts on the company's stock performance [4]. Group 4: Major Asset Restructuring Risks - The company is in the process of planning a major asset restructuring, with relevant audits and evaluations ongoing [5][6]. - The completion of the restructuring is subject to internal decision-making processes and approvals from the Shanghai Stock Exchange and the China Securities Regulatory Commission, introducing uncertainties regarding the timing and success of the transaction [5][6].

登录新浪财经APP 搜索【信披】查看更多考评等级 ● 公司于2026年2月6日召开第五届董事会第六次会议，审议通过《关于提前赎回"盟升转债"的议案》， 决定行使"盟升转债"的提前赎回权利，按照债券面值加当期应计利息的价格对赎回登记日登记在册 的"盟升转债"全部赎回。 ● 投资者所持"盟升转债"除在规定时限内通过二级市场继续交易或按照20.94元/股的转股价格进行转股 外，仅能选择以100元/张的票面价格加当期应计利息被强制赎回。若被强制赎回，可能面临较大投资损 失。 证券代码：688311 证券简称：盟升电子 公告编号：2026-006 转债代码：118045 转债简称：盟升转债 成都盟升电子技术股份有限公司关于提前赎回"盟升转债"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 自2026年1月19日至2026年2月6日期间，成都盟升电子技术股份有限公司（以下简称"公司"）股票满 足在连续三十个交易日中有十五个交易日的收盘价不低于"盟升转债"当期转股价格20.94元的130%（含 130%），即 ...

重要内容提示： 关于广州荔湾广药创业投资基金合伙企业（有限合伙） 完成私募基金备案暨关联交易进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ■ 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600332 证券简称：白云山 公告编号：2026-004 广州白云山医药集团股份有限公司 一、合作投资基本概述情况 2025 年12 月22 日，广州白云山医药集团股份有限公司（"本公司"）召 开第九届董事会第三十二次会议，审议通过了《关于广州广药二期基金股权投资合伙企业（有限合伙） 认购广州荔湾广药创业投资基金合伙企业（有限合伙）有 限合伙份额暨关联交易的议案》，同意本公司附属企业广州广药二期基金股权投 资合伙企业（有限合伙）（"广药二期基金"）与广州广药资本私募基金管理有 限公司（"广药资本"）、广州天使投资母基金创业投资合伙企业（有限合伙）（"天使母基金"）、广州 市荔湾区产业投资基金合伙企业（有限合伙）（"荔 湾产投基金"）合作设立广州荔湾广药创业投资基金合伙企业（有限合伙）（ "广药荔湾基金"）并签署 ...